I don’t think that’s even acceptable per regulatory standards. Even more so for autologus cell therapy products, when finished product sterility results won’t be available at the time of patient infusion of genetically modified cells.
---------------------------------
Deep Shah, MS
Global Regulatory Affairs CMC
Seattle, WA
---------------------------------
Original Message:
Sent: 02-Dec-2020
From: Sung Nyeo Shim
Subject: Grade A clean room for Cell & Gene therapy
Dear All,
Can a BSC, bio safety cabinet, in Grade B room be used for GMP production of cell & gene therapy, which requires Grade A clean room?
Thanks,
Sung
------------------------------
Sung Nyeo Shim
Consultant
Chicago IL
United States
------------------------------